DJ Gilead Sciences Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. (GILD) slipped 1.47% to $149.05 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.25% to 7,651.54 and Dow Jones Industrial Average falling 0.86% to 50,906.05.
This was the stock's second consecutive day of losses.
Gilead Sciences Inc. closed 5.24% short of its 52-week high of $157.29, which the company achieved on February 11th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 1.06% to $264.74, Pfizer Inc. $(PFE)$ fell 0.70% to $28.52, and Abbott Laboratories $(ABT)$ fell 2.10% to $98.83.
Data source: Dow Jones Market Data, FactSet. Data compiled September 30, 2026.